Rui-Cheng Xu
Overview
Explore the profile of Rui-Cheng Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang X, Xu Z, Yi T, Xu R, Li J, Zhang W, et al.
Mol Med Rep
. 2021 Jan;
23(3).
PMID: 33495805
Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that several pairings of panels in Fig. 5, as shown on p. 5599, were...
2.
Yang X, Xu Z, Yi T, Xu R, Li J, Zhang W, et al.
Mol Med Rep
. 2018 Feb;
17(4):5595-5600.
PMID: 29436645
Glioma is one of the most malignant forms of brain tumor, and has been of persistent concern due to its high recurrence and mortality rates, and limited therapeutic options. As...
3.
Mao S, Meng X, Xu Z, Zhang W, Jin X, Chen X, et al.
Mol Med Rep
. 2017 Mar;
15(4):2154-2162.
PMID: 28259939
Zing finger protein 580 (ZFP580) is a novel Cys2-His2 zinc-finger transcription factor that has an anti-apoptotic role in myocardial cells. It is involved in the endothelial transforming growth factor‑β1 (TGF‑β1)...
4.
Xu Z, Chen X, Jin X, Meng X, Zhou X, Fan F, et al.
J Proteomics
. 2015 Oct;
130:211-20.
PMID: 26435418
Hypoxic status alters the energy metabolism and induces cell injury in cardiomyocytes, and it further triggers the occurrence and development of cardiovascular diseases. Our previous studies have shown that salidroside...
5.
Meng X, Yu H, Guo M, Zhang W, Xu R
Zhongguo Ying Yong Sheng Li Xue Za Zhi
. 2015 Jan;
30(5):396-400.
PMID: 25581930
Objective: To elucidate whether ZFP580 is involved in the cardioprotective effects of intermittent hypobaric hypoxia (IHH) against myocardial ischemia/reperfusion (I/R) injury. Methods: Thirty two male Wistar rats were randomly divided...
6.
Meng X, Yu H, Zhang W, Wang T, Mai X, Liu H, et al.
PLoS One
. 2014 Apr;
9(4):e94635.
PMID: 24722354
Background: ZFP580 is a novel C2H2 type zinc-finger transcription factor recently identified by our laboratory. We previously showed that ZFP580 may be involved in cell survival and growth. The aim...
7.
Mai X, Xu Z, Chen X, Cao B, Xu R
Zhongguo Zhong Yao Za Zhi
. 2013 Feb;
37(22):3467-71.
PMID: 23373223
Objective: To study the effect of pseudolaric acid B (PLAB) on cell proliferation and cycle of human prostate carcinoma DU-145 cells. method: Its inhibitory effect on the cell growth was...
8.
Xu Z, Wang F, Gao M, Chen X, Shan N, Cheng S, et al.
J Steroid Biochem Mol Biol
. 2011 Jan;
125(3-5):181-91.
PMID: 21215801
Recent studies revealed the potential of Na(+)/K(+)-ATPase as a target for anticancer therapy and showed additional modes of action of cardiotonic steroids (CSs), a diverse family of naturally derived compounds,...
9.
Wang N, Xu R, Chen X, Hu W
Zhongguo Ying Yong Sheng Li Xue Za Zhi
. 2010 Dec;
24(2):177-83.
PMID: 21141520
Aim: To study the effect of Na+, K(+)-ATPase inhibition by ouabain on growth and death of vascular endothelial cells ECV304 and involved mechanisms. Methods: Growth inhibition of ouabain on ECV304...
10.
Xu Z, Wang F, Gao M, Chen X, Hu W, Xu R
Biol Pharm Bull
. 2010 May;
33(5):743-51.
PMID: 20460749
Recent research has shown that the Na(+)/K(+)-ATPase alpha1 subunit is a novel anti-cancer target, which plays pivotal roles in malignant cell ion transport, metabolism, migration and signal transduction. The purpose...